Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 249 entries
Sorted by: Best Match Show Resources per page
Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroids.

NDT plus

Bouamar R, Koper JW, van Rossum EF, Weimar W, van Gelder T.
PMID: 25949351
NDT Plus. 2009 Oct;2(5):384-6. doi: 10.1093/ndtplus/sfp082. Epub 2009 Jul 06.

A female patient developed avascular necrosis of the femoral heads after receiving low doses of glucocorticosteroids (GC) for 3 months. Genotyping of the GC receptor (GR) showed that she was heterozygous for the Bcl-1 allele and heterozygous for the...

Cite
Bouamar R, Koper JW, van Rossum EF, et al. Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroids. NDT Plus. 2009;2(5):384-6doi: 10.1093/ndtplus/sfp082.
Bouamar, R., Koper, J. W., van Rossum, E. F., Weimar, W., & van Gelder, T. (2009). Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroids. NDT plus, 2(5), 384-6. https://doi.org/10.1093/ndtplus/sfp082
Bouamar, Rachida, et al. "Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroids." NDT plus vol. 2,5 (2009): 384-6. doi: https://doi.org/10.1093/ndtplus/sfp082
Bouamar R, Koper JW, van Rossum EF, Weimar W, van Gelder T. Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroids. NDT Plus. 2009 Oct;2(5):384-6. doi: 10.1093/ndtplus/sfp082. Epub 2009 Jul 06. PMID: 25949351; PMCID: PMC4421398.
Copy Download .nbib Format: NLM
[What is the optimal diet?].

Revue medicale de Bruxelles

Van Gossum A.
PMID: 28525228
Rev Med Brux. 2016;37(4):289-293.

Food intake is expected to cover our basal requirements in energy, proteins, minerals, vitamins, trace elements and water. As it has been already suggested by Hippocrates, food can play a role in preventing but also in caring some diseases....

Cite
Van Gossum A. A quel régime faut-il se vouer ? [What is the optimal diet?]. Rev Med Brux. 2016;37(4):289-293
Van Gossum, A. (2016). A quel régime faut-il se vouer ? [What is the optimal diet?]. Revue medicale de Bruxelles, 37(4), 289-293.
Van Gossum, A. "A quel régime faut-il se vouer ?" [What is the optimal diet?]. Revue medicale de Bruxelles vol. 37,4 (2016): 289-293.
Van Gossum A. A quel régime faut-il se vouer ? [What is the optimal diet?]. Rev Med Brux. 2016;37(4):289-293. French. PMID: 28525228.
Copy Download .nbib Format: NLM
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.

Journal of the American College of Cardiology

Henriques JP, Hoebers LP, Råmunddal T, Laanmets P, Eriksen E, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Nijveldt R, van Rossum AC, Marques KM, Elias J, van Dongen IM, Claessen BE, Tijssen JG, van der Schaaf RJ.
PMID: 27712774
J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.

BACKGROUND: In 10% to 15% of patients with ST-segment elevation myocardial infarction (STEMI), concurrent coronary chronic total occlusion (CTO) in a non-infarct-related artery is present and is associated with increased morbidity and mortality.OBJECTIVES: The EXPLORE (Evaluating Xience and Left...

Cite
Henriques JP, Hoebers LP, Råmunddal T, et al. Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial. J Am Coll Cardiol. 2016;68(15):1622-1632doi: 10.1016/j.jacc.2016.07.744.
Henriques, J. P., Hoebers, L. P., Råmunddal, T., Laanmets, P., Eriksen, E., Bax, M., Ioanes, D., Suttorp, M. J., Strauss, B. H., Barbato, E., Nijveldt, R., van Rossum, A. C., Marques, K. M., Elias, J., van Dongen, I. M., Claessen, B. E., Tijssen, J. G., van der Schaaf, R. J. (2016). Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial. Journal of the American College of Cardiology, 68(15), 1622-1632. https://doi.org/10.1016/j.jacc.2016.07.744
Henriques, José P S, et al. "Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial." Journal of the American College of Cardiology vol. 68,15 (2016): 1622-1632. doi: https://doi.org/10.1016/j.jacc.2016.07.744
Henriques JP, Hoebers LP, Råmunddal T, Laanmets P, Eriksen E, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Nijveldt R, van Rossum AC, Marques KM, Elias J, van Dongen IM, Claessen BE, Tijssen JG, van der Schaaf RJ. Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial. J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744. PMID: 27712774.
Copy Download .nbib Format: NLM
Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy.

Oncotarget

Schrijver WAME, Schuurman K, van Rossum A, Peeters T, Ter Hoeve N, Zwart W, van Diest PJ, Moelans CB.
PMID: 28903441
Oncotarget. 2017 Feb 20;8(33):55550-55561. doi: 10.18632/oncotarget.15548. eCollection 2017 Aug 15.

Discordance in estrogen receptor alpha (ERα), progesterone receptor (PR), androgen receptor (AR) and human epidermal growth factor receptor 2 (HER2) status between primary breast cancers and solid distant metastases ("conversion") has been reported previously. Even though metastatic spread to...

Cite
Schrijver WAME, Schuurman K, van Rossum A. Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy. Oncotarget. 2017;8(33):55550-55561doi: 10.18632/oncotarget.15548.
Schrijver, W. A. M. E., Schuurman, K., van Rossum, A., Peeters, T., Ter Hoeve, N., Zwart, W., van Diest, P. J., & Moelans, C. B. (2017). Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy. Oncotarget, 8(33), 55550-55561. https://doi.org/10.18632/oncotarget.15548
Schrijver, Willemijne A M E, et al. "Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy." Oncotarget vol. 8,33 (2017): 55550-55561. doi: https://doi.org/10.18632/oncotarget.15548
Schrijver WAME, Schuurman K, van Rossum A, Peeters T, Ter Hoeve N, Zwart W, van Diest PJ, Moelans CB. Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy. Oncotarget. 2017 Feb 20;8(33):55550-55561. doi: 10.18632/oncotarget.15548. eCollection 2017 Aug 15. PMID: 28903441; PMCID: PMC5589680.
Copy Download .nbib Format: NLM
Comparison of the direct antiglobulin test and the eluate technique for diagnosing haemolytic disease of the newborn.

Practical laboratory medicine

van Rossum HH, de Kraa N, Thomas M, Holleboom CAG, Castel A, van Rossum AP.
PMID: 28932805
Pract Lab Med. 2015 Oct 22;3:17-22. doi: 10.1016/j.plabm.2015.10.001. eCollection 2015 Dec 01.

OBJECTIVE: The direct antiglobulin test (DAT) is an important tool for identification of haemolytic disease of the newborn (HDN) caused by erythrocyte immunization. Although this test has been used for decades, accurate insights into its diagnostic properties and optimal...

Cite
van Rossum HH, de Kraa N, Thomas M, et al. Comparison of the direct antiglobulin test and the eluate technique for diagnosing haemolytic disease of the newborn. Pract Lab Med. 2015;3:17-22doi: 10.1016/j.plabm.2015.10.001.
van Rossum, H. H., de Kraa, N., Thomas, M., Holleboom, C. A. G., Castel, A., & van Rossum, A. P. (2015). Comparison of the direct antiglobulin test and the eluate technique for diagnosing haemolytic disease of the newborn. Practical laboratory medicine, 317-22. https://doi.org/10.1016/j.plabm.2015.10.001
van Rossum, Huub H, et al. "Comparison of the direct antiglobulin test and the eluate technique for diagnosing haemolytic disease of the newborn." Practical laboratory medicine vol. 3 (2015): 17-22. doi: https://doi.org/10.1016/j.plabm.2015.10.001
van Rossum HH, de Kraa N, Thomas M, Holleboom CAG, Castel A, van Rossum AP. Comparison of the direct antiglobulin test and the eluate technique for diagnosing haemolytic disease of the newborn. Pract Lab Med. 2015 Oct 22;3:17-22. doi: 10.1016/j.plabm.2015.10.001. eCollection 2015 Dec 01. PMID: 28932805; PMCID: PMC5597716.
Copy Download .nbib Format: NLM
The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathways.

Frontiers in cellular neuroscience

Van Rossom S, Op de Beeck K, Hristovska V, Winderickx J, Van Camp G.
PMID: 26236191
Front Cell Neurosci. 2015 Jul 16;9:231. doi: 10.3389/fncel.2015.00231. eCollection 2015.

Cell death exists in many different forms. Some are accidental, but most of them have some kind of regulation and are called programmed cell death. Programmed cell death (PCD) is a very diverse and complex mechanism and must be...

Cite
Van Rossom S, Op de Beeck K, Hristovska V, et al. The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathways. Front Cell Neurosci. 2015;9:231doi: 10.3389/fncel.2015.00231.
Van Rossom, S., Op de Beeck, K., Hristovska, V., Winderickx, J., & Van Camp, G. (2015). The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathways. Frontiers in cellular neuroscience, 9231. https://doi.org/10.3389/fncel.2015.00231
Van Rossom, Sofie, et al. "The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathways." Frontiers in cellular neuroscience vol. 9 (2015): 231. doi: https://doi.org/10.3389/fncel.2015.00231
Van Rossom S, Op de Beeck K, Hristovska V, Winderickx J, Van Camp G. The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathways. Front Cell Neurosci. 2015 Jul 16;9:231. doi: 10.3389/fncel.2015.00231. eCollection 2015. PMID: 26236191; PMCID: PMC4504148.
Copy Download .nbib Format: NLM
On the mass measurement of charged particles, by counting grains in sensitive emulsions.

Comptes rendus hebdomadaires des seances de l'Academie des sciences

VAN ROSSUM L.
PMID: 18118509
C R Hebd Seances Acad Sci. 1949 Feb 21;228(8):676-8.

No abstract available.

Cite
VAN ROSSUM L. Sur la mesure de masse des particules chargées, par comptage des grains dans les émulsions sensibles. On the mass measurement of charged particles, by counting grains in sensitive emulsions. C R Hebd Seances Acad Sci. 1949;228(8):676-8
VAN ROSSUM, L. (1949). Sur la mesure de masse des particules chargées, par comptage des grains dans les émulsions sensibles. On the mass measurement of charged particles, by counting grains in sensitive emulsions. Comptes rendus hebdomadaires des seances de l'Academie des sciences, 228(8), 676-8.
VAN ROSSUM, L. "Sur la mesure de masse des particules chargées, par comptage des grains dans les émulsions sensibles." On the mass measurement of charged particles, by counting grains in sensitive emulsions. Comptes rendus hebdomadaires des seances de l'Academie des sciences vol. 228,8 (1949): 676-8.
VAN ROSSUM L. Sur la mesure de masse des particules chargées, par comptage des grains dans les émulsions sensibles. On the mass measurement of charged particles, by counting grains in sensitive emulsions. C R Hebd Seances Acad Sci. 1949 Feb 21;228(8):676-8. French. PMID: 18118509.
Copy Download .nbib Format: NLM
Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Götte MJ, Rüssel IK, de Roest GJ, Germans T, Veldkamp RF, Knaapen P, Allaart CP, van Rossum AC.
PMID: 20111641
Neth Heart J. 2010 Jan;18(1):31-7.

New developments and expanding indications have resulted in a significant increase in the number of patients with pacemakers and internal cardioverterdefibrillators (ICDs). Because of its unique capabilities, magnetic resonance imaging (MRI) has become one of the most important imaging...

Cite
Götte MJ, Rüssel IK, de Roest GJ, et al. Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective. Neth Heart J. 2010;18(1):31-7
Götte, M. J., Rüssel, I. K., de Roest, G. J., Germans, T., Veldkamp, R. F., Knaapen, P., Allaart, C. P., & van Rossum, A. C. (2010). Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 18(1), 31-7.
Götte, M J W, et al. "Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 18,1 (2010): 31-7.
Götte MJ, Rüssel IK, de Roest GJ, Germans T, Veldkamp RF, Knaapen P, Allaart CP, van Rossum AC. Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective. Neth Heart J. 2010 Jan;18(1):31-7. PMID: 20111641; PMCID: PMC2810033.
Copy Download .nbib Format: NLM
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van der Laan A, Hirsch A, Nijveldt R, van der Vleuten PA, van der Giessen WJ, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ.
PMID: 19127324
Neth Heart J. 2008 Dec;16(12):436-9. doi: 10.1007/BF03086194.

During the last decennium, the role of bone marrow mononuclear cells (BMMC) has been underscored in the healing process after acute myocardial infarction (AMI). Although these cells improve left ventricular recovery after AMI in experimental studies, results from large-scale...

Cite
van der Laan A, Hirsch A, Nijveldt R, et al. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J. 2008;16(12):436-9doi: 10.1007/BF03086194.
van der Laan, A., Hirsch, A., Nijveldt, R., van der Vleuten, P. A., van der Giessen, W. J., Doevendans, P. A., Waltenberger, J., Ten Berg, J. M., Aengevaeren, W. R., Zwaginga, J. J., Biemond, B. J., van Rossum, A. C., Tijssen, J. G., Zijlstra, F., & Piek, J. J. (2008). Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 16(12), 436-9. https://doi.org/10.1007/BF03086194
van der Laan, A, et al. "Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 16,12 (2008): 436-9. doi: https://doi.org/10.1007/BF03086194
van der Laan A, Hirsch A, Nijveldt R, van der Vleuten PA, van der Giessen WJ, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J. 2008 Dec;16(12):436-9. doi: 10.1007/BF03086194. PMID: 19127324; PMCID: PMC2612115.
Copy Download .nbib Format: NLM
Double aortic arch.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Nijveldt R, Germans T, Beek AM, Götte MJ, van Rossum AC.
PMID: 17612690
Neth Heart J. 2007;15(6):229-30. doi: 10.1007/BF03085987.

No abstract available.

Cite
Nijveldt R, Germans T, Beek AM, et al. Double aortic arch. Neth Heart J. 2007;15(6):229-30doi: 10.1007/BF03085987.
Nijveldt, R., Germans, T., Beek, A. M., Götte, M. J., & van Rossum, A. C. (2007). Double aortic arch. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 15(6), 229-30. https://doi.org/10.1007/BF03085987
Nijveldt, R, et al. "Double aortic arch." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 15,6 (2007): 229-30. doi: https://doi.org/10.1007/BF03085987
Nijveldt R, Germans T, Beek AM, Götte MJ, van Rossum AC. Double aortic arch. Neth Heart J. 2007;15(6):229-30. doi: 10.1007/BF03085987. PMID: 17612690; PMCID: PMC1896140.
Copy Download .nbib Format: NLM
Phylogenetic Profiles Reveal Structural and Functional Determinants of Lipid-binding.

Journal of proteomics & bioinformatics

Hong Y, Chalkia D, Ko KD, Bhardwaj G, Chang GS, van Rossum DB, Patterson RL.
PMID: 19946567
J Proteomics Bioinform. 2009 Mar 21;2:139-149. doi: 10.4172/jpb.1000071.

One of the major challenges in the genomic era is annotating structure/function to the vast quantities of sequence information now available. Indeed, most of the protein sequence database lacks comprehensive annotation, even when experimental evidence exists. Further, within structurally...

Cite
Hong Y, Chalkia D, Ko KD, et al. Phylogenetic Profiles Reveal Structural and Functional Determinants of Lipid-binding. J Proteomics Bioinform. 2009;2:139-149doi: 10.4172/jpb.1000071.
Hong, Y., Chalkia, D., Ko, K. D., Bhardwaj, G., Chang, G. S., van Rossum, D. B., & Patterson, R. L. (2009). Phylogenetic Profiles Reveal Structural and Functional Determinants of Lipid-binding. Journal of proteomics & bioinformatics, 2139-149. https://doi.org/10.4172/jpb.1000071
Hong, Yoojin, et al. "Phylogenetic Profiles Reveal Structural and Functional Determinants of Lipid-binding." Journal of proteomics & bioinformatics vol. 2 (2009): 139-149. doi: https://doi.org/10.4172/jpb.1000071
Hong Y, Chalkia D, Ko KD, Bhardwaj G, Chang GS, van Rossum DB, Patterson RL. Phylogenetic Profiles Reveal Structural and Functional Determinants of Lipid-binding. J Proteomics Bioinform. 2009 Mar 21;2:139-149. doi: 10.4172/jpb.1000071. PMID: 19946567; PMCID: PMC2782862.
Copy Download .nbib Format: NLM
Triple resonance cross-polarization for more sensitive 13C MAS NMR spectroscopy of deuterated proteins.

Chemphyschem : a European journal of chemical physics and physical chemistry

Akbey U, Camponeschi F, van Rossum BJ, Oschkinat H.
PMID: 21656893
Chemphyschem. 2011 Aug 01;12(11):2092-6. doi: 10.1002/cphc.201100084. Epub 2011 Jun 08.

Save the last WALTZ for me: the use of simultaneous proton and deuterium cross-polarization for (13)C CPMAS NMR spectroscopy in highly deuterated proteins is discussed. The aim of the new method introduced herein, triple-resonance cross-polarization, is to increase the...

Cite
Akbey U, Camponeschi F, van Rossum BJ, et al. Triple resonance cross-polarization for more sensitive 13C MAS NMR spectroscopy of deuterated proteins. Chemphyschem. 2011;12(11):2092-6doi: 10.1002/cphc.201100084.
Akbey, U., Camponeschi, F., van Rossum, B. J., & Oschkinat, H. (2011). Triple resonance cross-polarization for more sensitive 13C MAS NMR spectroscopy of deuterated proteins. Chemphyschem : a European journal of chemical physics and physical chemistry, 12(11), 2092-6. https://doi.org/10.1002/cphc.201100084
Akbey, Umit, et al. "Triple resonance cross-polarization for more sensitive 13C MAS NMR spectroscopy of deuterated proteins." Chemphyschem : a European journal of chemical physics and physical chemistry vol. 12,11 (2011): 2092-6. doi: https://doi.org/10.1002/cphc.201100084
Akbey U, Camponeschi F, van Rossum BJ, Oschkinat H. Triple resonance cross-polarization for more sensitive 13C MAS NMR spectroscopy of deuterated proteins. Chemphyschem. 2011 Aug 01;12(11):2092-6. doi: 10.1002/cphc.201100084. Epub 2011 Jun 08. PMID: 21656893.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 249 entries